18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis

Surgical Oncology

Volumn 22, Issue 2, 2013, Pages 139-143

  Hong, Shikai ^a   Li, Junhong ^b   Wang, Shengying ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Conventional imaging; Distant metastases; Meta analysis; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BONE SCINTISCANNING; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; ECHOGRAPHY; EMBASE; FALSE POSITIVE RESULT; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; BONE; BREAST TUMOR; FEMALE; META ANALYSIS (TOPIC); METASTASIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; BREAST NEOPLASMS; DIAGNOSTIC USE;

BONE AND BONES; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878843943     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2013.03.001     Document Type: Review

References (28)

1. R.A. Smith, and R. Guisti The epidemiology of breast cancer L.W. Basset, V.P. Jackson, Diagnosis of diseases of the breast 1996 Saunders Philadelphia 293 316
2. A.C. Voogd, G. van Tienhoven, H.L. Peterse, M.A. Crommelin, E.J. Rutgers, and C.J. van de Velde Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients Cancer 85 1999 437 446
3. G. van Tienhoven, A.C. Voogd, J.L. Peterse, M. Nielsen, K.W. Andersen, and F. Mignolet EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM) Eur J Cancer 35 1999 32 38
4. J. Dose, C. Bleckmann, S. Bachmann, K.H. Bohuslavizki, J. Berger, and L. Jenicke Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients Nucl Med Commun 23 2002 857 864
5. H. Schirrmeister, T. Kuhn, A. Guhlmann, C. Santjohanser, T. Hörster, and K. Nüssle Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures Eur J Nucl Med 28 2001 351 358
6. D. Fuster, J. Duck, P. Paredes, M. Velasco, M. Muñoz, and G. Santamaría Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 2008 4746 4751
7. P. Whiting, A.W. Rutjes, J.B. Reitsma, P.M. Bossuyt, and J. Kleijnen The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
8. H. Chu, and S.R. Cole Bivariate meta-analysis of sensitivity and specificity with sparse data: a general linear mixed model approach J Clin Epidemiol 59 2006 1331 1332
9. J.B. Reitsma, A.S. Glas, A.W. Rutjes, R.J. Scholten, P.M. Bossuyt, and A.H. Zwinderman Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J Clin Epidemiol 58 2005 982 990
10. R. Jaeschke, G.H. Guyatt, D.L. Sackett The Evidence-Based Medicine Working Group Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 271 1994 703 707
11. Z. Garami, Z. Hascsi, J. Varga, T. Dinya, M. Tanyi, and I. Garai The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan Eur J Surg Oncol 38 2012 31 37
12. M. Bernsdorf, A.K. Berthelsen, V.T. Wielenga, N. Kroman, D. Teilum, and T. Binderup Preoperative PET/CT in early stage breast cancer Ann Oncol 23 2012 2277 2282
13. B.R. Mittal, K. Manohar, R. Kashyap, A. Bhattacharya, B. Singh, and G. Singh The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging Hell J Nucl Med 14 2011 135 139
14. D. Groheux, S. Giacchetti, M. Delord, E. Hindié, L. Vercellino, and C. Cuvier 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging J Nucl Med 54 2013 5 11
15. G.P. Schmidt, A. Baur-Melnyk, A. Haug, V. Heinemann, I. Bauerfeind, and M.F. Reiser Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT Eur J Radiol 65 2008 47 58
16. A. Dirisamer, B.S. Halpern, D. Flory, F. Wolf, M. Beheshti, and M.E. Mayerhoefer Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer Eur J Radiol 73 2010 294 299
17. T.S. Aukema, E.J. Rutgers, W.V. Vogel, H.J. Teertstra, H.S. Oldenburg, and M.T. Vrancken Peeters The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques Eur J Surg Oncol 36 2010 387 392
18. N. Niikura, C.M. Costelloe, J.E. Madewell, N. Hayashi, T.K. Yu, and J. Liu FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer Oncologist 16 2011 1111 1119
19. B.B. Koolen, M.J. Vrancken Peeters, T.S. Aukema, W.V. Vogel, and H.S. Oldenburg 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques Breast Cancer Res Treat 131 2012 117 126
20. K. Manohar, B.R. Mittal, R. Senthil, R. Kashyap, A. Bhattacharya, and G. Singh Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma Nucl Med Commun 33 2012 591 596
21. C. Riegger, J. Herrmann, J. Nagarajah, J. Hecktor, S. Kuemmel, and F. Otterbach Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients Eur J Nucl Med Mol Imaging 39 2012 852 863
22. Y.J. Choi, Y.D. Shin, Y.H. Kang, M.S. Lee, M.K. Lee, and B.S. Cho The effects of preoperative (18) F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study J Breast Cancer 15 2012 441 448
23. A.S. Glas, J.G. Lijmer, M.H. Prins, G.J. Bonsel, and P.M. Bossuyt The diagnostic odds ratio: a single indicator of test performance J Clin Epidemiol 56 2003 1129 1135
24. J.J. Deeks Systematic reviews of evaluations of diagnostic and screening tests M.M. Egger, G.D. Smith, D.G. Altman, Systematic reviews in health care: meta-analysis in context 2001 BMJ Publishing Group London, UK 248 282
25. R. Jaeschke, G. Guyatt, and J. Lijmer Diagnostic tests G. Guyatt, D. Rennie, Use guides to the medical literature: a manual for evidence-based clinical practice 2002 AMA Press Chicago, IL 121 140
26. R.E. Walker, and S.J. Eustace Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications Semin Musculoskelet Radiol 5 2001 5 20
27. J. Barkhausen, H.H. Quick, T. Lauenstein, M. Goyen, S.G. Ruehm, and G. Laub Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study Radiology 220 2001 252 256
28. G. Xu, C. Li, L. Zhao, and Z. He Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis Ann Oncol 24 2013 96 105